New Amino Acids Research from Yeungnam University Described (SPROUTY2, a Negative Feedback Regulator of Receptor Tyrosine Kinase Signaling, Associated with Neurodevelopmental Disorders: Current Knowledge and Future Perspectives).

A recent study from Yeungnam University in South Korea explores the role of SPROUTY2 (SPRY2) as a negative regulator of receptor tyrosine kinase (RTK) signaling, with implications for neurodevelopmental disorders. The research highlights the potential therapeutic applications of targeting SPRY2 in the RAS/ERK pathway to address neurological conditions. This study provides insights into the structure of SPRY2, its interactions in RTK signaling cascades, and its potential role in neurodevelopmental disorders, offering future therapeutic possibilities. [Extracted from the article]